Jump to content

SciTechPress

Zipping Your Genes: Optimizing Diagnoses with Genetic Testing

Topic Summary

Created

Last Reply

Replies

Views

SciTechPress -
SciTechPress -
1
13

Top Posters


Recommended Posts

wikipedia GIF

Biogen and Invitae, two leading biotechnology and genomics companies, recently announced the availability of a rapid results genetic testing program for spinal muscular atrophy (SMA). The test will reduce the definitive diagnosis from 21 to just four days, at no charge to individuals in the U.S.6 SMA is often a life-threatening disease, characterized by loss of motor neurons in the spinal cord and lower brain stem. As it progresses, the disease can cause severe and progressive muscle atrophy and weakness.7 Faster diagnostics will allow for earlier intervention, treatment and, potentially, better medical outcomes for patients with SMA.

--------------

 

6. Global Newswire, “Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients,” Aug 20, 2019.

7. Ibid.

Share this post


Link to post
Share on other sites


  • Forum Statistics

    61,175
    Total Topics
    111,909
    Total Posts
  • Member Statistics

    16,400
    Total Members
    1,592
    Most Online
    Susan Berger
    Newest Member
    Susan Berger
    Joined




×
×
  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.